(Q39062317)
Statements
1 reference
SL1122-37, a novel derivative of sorafenib, has greater effects than sorafenib on the inhibition of human hepatocellular carcinoma (HCC) growth and prevention of angiogenesis (English)
1 reference
Yizhuo Qin
1 reference
Yuyin Lu
1 reference
Ruiqi Wang
1 reference
Wenbao Li
1 reference
Xianjun Qu
1 reference
1 October 2013
1 reference
1 reference
7
1 reference
5
1 reference
237-244
1 reference
Identifiers
1 reference